Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

narcolepsy 3 - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

narcolepsy 3

MONDO:0012179

Also known as:NRCLP3

Overview

A rare, autosomal dominant form of narcolepsy mapped to chromosome 21q, between genetic markers D21S267 and ABCG1. 6 patients with the milder form were DQB1*0602-positive.

GeneticsAutosomal dominant

Clinical Presentation

Built from Human Phenotype Ontology (HPO) phenotype annotations and GeneReviews clinical descriptions. Features represent findings documented across known cases — not an exhaustive list of possible symptoms.

Features include always present findings: Abnormal rapid eye movement sleep. 5 total HPO annotations.

Organ System	Phenotype Count	Example Features
Brain and nerves	2	Hypnagogic hallucination, Excessive daytime somnolence
Eyes

Diagnosis

Biomarker and diagnostic research for narcolepsy 3 has been reported in the published literature.

Prognosis

Phenotype severity distribution: 1 always present feature.

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for narcolepsy 3.

202 publications have been identified in PubMed for narcolepsy 3. Kisho has analyzed 94 by research type. Research spans Epidemiology / Natural History (32%), Basic Science / Preclinical (18%), and Review / Meta-Analysis (16%).

Research Type	Count	% of Total
Disease patterns and progression	30	32%

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 12:36 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Patient Support

Financial & Access Support (External Programs)

View all programs →

Narcolepsy Medical Assistance

Medical AssistanceWaitlistOperated by National Organization for Rare Disorders

Visit official site

Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.

Are you a patient organization for this condition?

Claim this page and your organization will be listed here for patients and families to find.

Be recognized as the official organization
Get notified of new trials, FDA decisions, and research
Appear in the disease page directory
Embed this content on your website — free

Medical References

External Resources

OMIM

Online Mendelian Inheritance in Man

OMIM:609039

GARD

Genetic and Rare Diseases Info Center

GARD:15447

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Kisho

narcolepsy 3

Overview

Clinical Presentation

Diagnosis

Prognosis

Research Landscape

Patient Support

Financial & Access Support (External Programs)

Are you a patient organization for this condition?

Medical References

External Resources

OMIM

GARD

Questions for Your Care Team

Questions for Your Care Team

Explore clinical features

Recent Publications

narcolepsy 3

Overview

Clinical Presentation

Diagnosis

Prognosis

Research Landscape

Patient Support

Financial & Access Support (External Programs)

Are you a patient organization for this condition?

Medical References

External Resources

OMIM

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Explore clinical features

Recent Publications